Roles of the AGE-RAGE system in vascular injury in diabetes

Annals of the New York Academy of Sciences

Volumn 902, Issue , 2000, Pages 163-172

  Yamamoto, Yasuhiko ^a   Yamagishi, Sho Ichi ^a   Yonekura, Hideto ^a   Doi, Toshio ^b   Tsuji, Hiroko ^b   Kato, Ichiro ^c   Takasawa, Shin ^c   Okamoto, Hiroshi ^c   Abedin, Joynal ^a   Tanaka, Nobushige ^a   Sakurai, Shigeru ^a   Migita, Hideyuki ^a   Unoki, Hiroyuki ^a   Wang, Hua ^a   Zenda, Takahiro ^a   Wu, Ping Sheng ^a   Segawa, Yasunori ^a   Higashide, Tomomi ^a   Kawasaki, Kazuo ^a   Yamamoto, Hiroshi ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COLLAGEN TYPE 4; RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; COLLAGEN SYNTHESIS; CONFERENCE PAPER; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; HUMAN; MESANGIUM; NONHUMAN; PERICYTE; VASCULAR ENDOTHELIUM;

ANIMALIA; BOVINAE; MUS MUSCULUS;

EID: 0034084263     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06311.x     Document Type: Conference Paper

References (15)

1. 1. YAMAGISHI, S., K. KOBAYASHI & H. YAMAMOTO. 1993. Vascular pericytes not only regulate growth, but also preserve prostacyclin-producing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells. Biochem. Biophys. Res. Commun. 190: 418-425.
2. 2. MAILLARD L.C. 1912. Action des acides amines sur les sucres; formation des melanoidines par voie methodique. CR Acad. Sci. 154: 66-68.
3. 3. BROWNLEE, M., A. CERAMI & H. VLASSARA. 1988. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318: 1315-1321.
4. 4. YAMAGISHI, S., H. YONEKURA, Y. YAMAMOTO, H. FUJIMORI & H. YAMAMOTO. 1998. AGE and endothelial cells. J. Atheroscler. Thromb. 4: 141-143.
5. 5. YAMAGISHI, S., H. YONEKURA, Y. YAMAMOTO, K. KATSUNO, F. SATO, I. MITA, H. OOKA, N. SATOZAWA, T. KAWAKAMI, M. NOMURA & H. YAMAMOTO. 1997. Advanced glycation endproducts-driven angiogenesis in vitro: Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J. Biol. Chem. 272: 8723-8730.
6. 6. YAMAGISHI, S., C.-C. HSU, M. TANIGUCHI, S. HARADA, K. OHSAWA, K. KOBAYASHI & H. YAMAMOTO. 1995. Receptor-mediated toxicity to pericytes of advanced glycosylation end products: A possible mechanism of pericyte loss in diabetic microangiopathy. Biochem. Biophys. Res. Commun. 213: 681-687.
7. 7. NEEPER, M., A.M. SCHMIDT, J. BRETT, S.D. YAN, F. WANG, Y-C.E. PNA, K. ELLISTON, D. STERN & A. SHAW. 1992. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267: 14998-15004.
8. 8. YAMAMOTO, Y., S. YAMAGISHI, C.-C. HSU & H. YAMAMOTO. 1996. Advanced glycation endproducts-receptor interactions stimulate the growth of human pancreatic cancer cells through the induction of platelet-derived growth factor-B. Biochem. Biophys. Res. Commun. 222: 700-703.
9. 9. YAMAGISHI, S., Y. YAMAMOTO, S. HARADA, C.-C. HSU, C.-C. & H. YAMAMOTO. 1996. Advanced glycosylation end products stimulate the growth but inhibit the prostacyclin-producing ability of endothelial cells through interactions with their receptors. FEBS Lett. 384: 103-106.
10. 10. YAMAGISHI, S., H. FUJIMORI, H. YONEKURA, Y. YAMAMOTO & H. YAMAMOTO. 1998. Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. Diabetologia 41: 1435-1441.
11. 11. NOMURA, M., S. YAMAGISHI, S. HARADA, Y. HAYASHI, T. YAMASHIMA, J. YAMASHITA & H. YAMAMOTO. 1995. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J. Biol. Chem. 270: 28316-28324.
12. 12. TSUJI, H., N. IEHARA, T. MASEGI, M. IMURA, J. OHKAWA, H. ARAI, K. ISHII, T. KITA & T. DOI. 1998. Ribozyme targeting of receptor for advanced glycation end products in mesangial cells. Biochem. Biophys. Res. Commun. 245: 583-588.
13. 13. SEGAWA, Y., Y. SHIRAO, S. YAMAGISHI, T. HIGASHIDA, M. KOBAYASHI, K. KATSUNO, A. IYOBE, H. HARADA, F. SATO, H. MIYATA, H. ASAI, A. NISHIMURA, M. TAKAHIRA, T. SOUNO, Y. SEGAWA, K. MAEDA, K. SHIMA, A. MIZUNO, H. YAMAMOTO & K. KAWASAKI. 1998. Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. Ophthalmic Res. 30: 333-339.
14. 14. YAMAMOTO, Y. et al. In preparation.
15. 15. TAKAMURA, T., I. KATO, N. KIMURA, T. NAKAZAWA, H. YONEKURA, S. TAKASAWA & H. OKAMOTO. 1998. Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic β cells develop insulin-dependent diabetes without insulitis. 273: 2493-2496.